JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Home・Stock List・Vivani Medical

Vivani Medical

Closed

1.34 0.75

Buy Sell

Overview

Share price change

24h

Current

Min

1.32

Max

1.34

Key metrics
By Trading Economics
Income	-103K -6.6M
Employees	42

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+175.74% upside

Dividends
By Dow Jones
Next Earnings	11 May 2026

Market Stats
By TradingEconomics
Market Cap	25M 98M
Previous open	0.59
Previous close	1.34

Vivani Medical Chart

Past performance is not a reliable indicator of future results.

Related News

1 May 2026, 21:36 UTC

Acquisitions, Mergers, Takeovers

FTC Requires 365 Retail Markets to Divest Micromarket Kiosk Business to Clear Acquisition of Cantaloupe

1 May 2026, 20:40 UTC

Acquisitions, Mergers, Takeovers

Meta Platforms Acquires Humanoid Robot Startup Assured Robot Intelligence

1 May 2026, 18:37 UTC

Major Market Movers

Senseonic Shares Slide on Underwritten Offering Price

1 May 2026, 16:46 UTC

Major Market Movers

Stellantis, Ferrari Fall on Trump Plan to Increase Tariff on European Cars, Trucks

2 May 2026, 19:57 UTC

Acquisitions, Mergers, Takeovers

Berkshire CEO Greg Abel Takes the Stage, Making a Case for the Post-Buffett Era -- 3rd Update

2 May 2026, 15:24 UTC

Earnings

Berkshire CEO Greg Abel Takes the Stage, Talks Through Quarterly Results -- Update

2 May 2026, 12:46 UTC

Earnings

Acquisitions, Mergers, Takeovers

Berkshire Profits More Than Double on Gains in Insurance, Railroad, Energy Businesses -- WSJ

2 May 2026, 08:20 UTC

Market Talk

Financial Services Roundup: Market Talk

1 May 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

1 May 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

1 May 2026, 20:42 UTC

Earnings

Western Digital Beats Earnings Estimates. The Stock Is Falling Anyway. -- Barrons.com

1 May 2026, 19:33 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

1 May 2026, 19:33 UTC

Market Talk

Change in Fed Leadership May Hamper Crypto Rebound -- Market Talk

1 May 2026, 19:18 UTC

Market Talk

Major News Events

Oil Rises for Second Consecutive Week Amid Middle East Standoff -- Market Talk

1 May 2026, 19:13 UTC

Market Talk

Natural Gas Rises as Markets Wait for Warmer Temperatures -- Market Talk

1 May 2026, 18:36 UTC

Earnings

3 Takeaways From Apple Earnings. The Stock Is Surging. -- Barrons.com

1 May 2026, 18:35 UTC

Earnings

Moderna's Covid Vaccine Is Driving Growth Again. The Stock Is Down Anyway. -- Barrons.com

1 May 2026, 18:28 UTC

Earnings

These Stocks Are Today's Movers: Apple, Sandisk, Roblox, Intel, Ferrari, Atlassian, Western Digital, Clorox, Paramount Skydance, and More -- Barrons.com

1 May 2026, 18:27 UTC

Market Talk

Gold and Silver Higher for the Day, Lower For The Week -- Market Talk

1 May 2026, 18:14 UTC

Acquisitions, Mergers, Takeovers

Barclays Completes Acquisition of Best Egg

1 May 2026, 18:04 UTC

Earnings

The First $6 Trillion Company May Not Be Nvidia -- Barrons.com

1 May 2026, 17:43 UTC

Market Talk

Home Sales in San Francisco Jump 22.2% in March -- Market Talk

1 May 2026, 17:37 UTC

Market Talk

Crypto 'Fear and Greed Index' Returns to Neutral Reading After Brief Dip -- Market Talk

1 May 2026, 17:30 UTC

Market Talk

Earnings

Apple's 2Q Print, 3Q Guide Set Up Stock to Outperform -- Market Talk

1 May 2026, 17:28 UTC

Market Talk

Earnings

Apple's Shift From Net Cash Neutral Goal Seen as Cryptic Signal -- Market Talk

1 May 2026, 17:21 UTC

Market Talk

Earnings

Apple Seen Absorbing Higher Memory Costs -- Market Talk

1 May 2026, 17:19 UTC

Market Talk

Major News Events

U.S. Oil Rig Count Rises by 1 to 408 -- Market Talk

1 May 2026, 16:38 UTC

Market Talk

Institutional Markets Begin to Trade on Event Contracts -- Market Talk

1 May 2026, 16:23 UTC

Acquisitions, Mergers, Takeovers

Paramount Skydance Gets a Double Upgrade. It's the Warner Bros. Deal. -- Barrons.com

1 May 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

Peer Comparison

Price change

Vivani Medical Forecast

Price Target

By TipRanks

175.74% upside

12 Months Forecast

Average 3.75 USD 175.74%

High 4 USD

Low 3.5 USD

Based on 2 Wall Street analysts offering 12 month price targets forVivani Medical - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Based on 2 analysts giving stock ratings to Vivani Medical - Dist in the past 3 months.

Financials

Selling and administration expenses

Pre-tax profit

Sales

Operating profit

About Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.